Sapu Bioscience is an immuno-oncology company dedicated to the development of first-in-class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Sapu Bioscience, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single-agent activity in relapsed/refractory cancer patients in clinical trial settings. Sapu Bioscience is seeking to...
Sapu Bioscience is an immuno-oncology company dedicated to the development of first-in-class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of Sapu Bioscience, is a first-in-class anti-TGF-βRNA therapeutic that exhibited single-agent activity in relapsed/refractory cancer patients in clinical trial settings. Sapu Bioscience is seeking to leverage its deep expertise in drug development to improve treatment outcomes and the survival of cancer patients with a special emphasis on rare pediatric cancers.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.